OCLI Ophthalmologist First in Nassau County to Implant Vivity, Innovative Presbyopia-Correcting Intraocular Lens
New intraocular lens uses pioneering X-WAVE™ technology to create extended range of vision for cataract patients NEW YORK, N.Y.—December 2, 2020—OCLI, a world-renowned, multi-practice ophthalmology group in Long Island, today announced that Chasidy Singleton, MD, board-certified ophthalmologist and laser cataract surgeon, has the distinction of being the first doctor in Nassau County Long Island to…
OCLI Partners with Bionic Sight in Clinical Trial of New Treatment for Blindness
State-of-the-art eye care practice to assess Bionic Sight’s optogenetic therapy for blindness caused by retinitis pigmentosa NEW YORK, N.Y.—November 17, 2020—OCLI, one of the leading ophthalmology practices in the United States, today announced that it’s starting a clinical trial in partnership with Bionic Sight, the developer of BS01, a new investigational therapy for patients with…
Visus Therapeutics Launches and Announces Clinical Development Program for Novel Presbyopia Eye Drop
Patent Assets Acquired from Acclaimed Ophthalmologist and Innovator Herb Kaufman, M.D., to Progress to Phase II Studies Eric Donnenfeld, M.D., Appointed Leader of Clinical Advisory Board, Bringing World-Class Ophthalmology Expertise as Company Moves Into Clinical Development Visus Therapeutics Inc. today (September 28, 2020) announced its launch and clinical development program for a novel eye drop…
